Literature DB >> 21246602

Retinal nerve fiber layer thickness in vigabatrin-exposed patients.

Lisa M Clayton1, Marita Dévilé, Trusjen Punte, Constantinos Kallis, Gerrit-Jan de Haan, Josemir W Sander, James Acheson, Sanjay M Sisodiya.   

Abstract

OBJECTIVE: Vigabatrin-associated visual field loss (VAVFL) occurs in 25 to 50% of exposed patients and is routinely monitored using perimetry, which has inherent limitations. Using optical coherence tomography (OCT), retinal nerve fiber layer (RNFL) thinning has been described in a small number of vigabatrin-exposed patients. We explored the relationship between RNFL thickness and visual field size, to determine whether OCT is a suitable tool to use in patients exposed to vigabatrin.
METHODS: Two hundred one vigabatrin-exposed subjects with epilepsy, divided into 2 groups, and 90 healthy controls participated. Visual fields were obtained using Goldmann kinetic perimetry and quantified using mean radial degrees (MRD). RNFL imaging was performed using either spectral-domain (Group 1) or time-domain (Group 2) OCT.
RESULTS: Thirty-nine of 201 (19.4%) patients were unable to perform perimetry. Thirteen (6.5%) patients were unable to perform OCT. A total of 51.6% of patients showed VAVFL. Average RNFL thickness was significantly thinner in patients (77.9 μm) compared to healthy controls (93.6 μm) (p < 0.001). There was a strong correlation between MRD and average RNFL thickness for Group 1 (r = 0.768, p < 0.001) and Group 2 (r = 0.814, p < 0.001). OCT RNFL imaging showed high repeatability.
INTERPRETATION: OCT provides a useful tool to assess people exposed to vigabatrin, and can provide an accurate estimate of the extent of visual field loss in the absence of a reliable direct measure of the visual field. The strong linear relationship found between RNFL thickness and visual field size provides some evidence that irreversible VAVFL may be related to loss of retinal ganglion cell axons.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21246602     DOI: 10.1002/ana.22266

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Limiting Retinal Toxicity of Vigabatrin in Children With Infantile Spasms.

Authors:  Prakash Kotagal
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

2.  Modelling the risk of visual field loss arising from long-term exposure to the antiepileptic drug vigabatrin: a cross-sectional approach.

Authors:  John M Wild; David L Fone; Saleh Aljarudi; Charlotte Lawthom; Philip E M Smith; Robert G Newcombe; Gareth D Lewis
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

3.  Electroretinographic (ERG) responses in pediatric patients using vigabatrin.

Authors:  Anne Moskowitz; Ronald M Hansen; Susan E Eklund; Anne B Fulton
Journal:  Doc Ophthalmol       Date:  2012-03-20       Impact factor: 2.379

4.  Evaluation of inner retinal layers with optic coherence tomography in vigabatrin-exposed patients.

Authors:  Betül Tuğcu; Mesrure Köseoğlu Bitnel; Fatma Selin Kaya; Betül Tekin Güveli; Dilek Ataklı
Journal:  Neurol Sci       Date:  2017-05-16       Impact factor: 3.307

5.  Neuro-ophthalmology: Five new things.

Authors:  Wayne T Cornblath
Journal:  Neurol Clin Pract       Date:  2012-06

6.  The Topographical Relationship between Visual Field Loss and Peripapillary Retinal Nerve Fibre Layer Thinning Arising from Long-Term Exposure to Vigabatrin.

Authors:  John M Wild; Saleh Aljarudi; Philip E M Smith; Carlo Knupp
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

Review 7.  Applications of optical coherence tomography in pediatric clinical neuroscience.

Authors:  Robert A Avery; Raneem D Rajjoub; Carmelina Trimboli-Heidler; Amy T Waldman
Journal:  Neuropediatrics       Date:  2015-03-24       Impact factor: 1.947

8.  Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy.

Authors:  John M Wild; Philip E M Smith; Carlo Knupp
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

9.  Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex.

Authors:  Leonardo Emberti Gialloreti; Romina Moavero; Sara Marciano; Matteo Pardini; Francesca Benassi; Maria Giulia Mutolo; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2015-04-25       Impact factor: 1.475

10.  Retinal defect in children with infantile spasms of varying etiologies: An observational study.

Authors:  Michelle T McFarlane; Tom Wright; Blathnaid McCoy; O Carter Snead; Carol A Westall
Journal:  Neurology       Date:  2019-12-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.